Physician profile
Jonathan Lane
NPI 1104288455
$1,315.00
in general payments reported to CMS, 2019-2025
8 companies · $57.64 in 2025
The $57.64 reported for 2025 was less than what a typical General Practice (Dentist) provider received nationally (typical 2025 total: $74.60).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $32.54 · 2022: $695 · 2023: $448 · 2024: $81.95 · 2025: $57.64.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Gift: $358 · Food and Beverage: $230.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Gift | $357.68 |
| Food and Beverage | $229.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ultradent Products INC | $850.62 | 2022-2023 | Opalescence |
| Straumann USA LLC | $306.23 | 2022-2025 | |
| Philips North America LLC | $42.28 | 2024-2025 | (8614) Protectiveclean 4100-4300, Zoom In-Office Kits |
| Nobel Biocare USA | $37.41 | 2023 | Nobelactive |
| Dentsply Sirona INC | $32.54 | 2021 | |
| Biohorizons Implant Systems INC. | $29.38 | 2023 | Biohorizons |
| Align Technology, INC. | $9.49 | 2024 | Invisalign |
| Voco America INC. | $7.05 | 2025 | Voco Profluorid Varnish, Admira Fusion X-Tra, Meron Plus Qm |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Lane listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.